Department of Defense Opioid Prescriber Safety Training Program
Update (2/26/2024):
This course is currently under revision and is not eligible for CEUs/CMEs at this time; however, it is still required to meet DHA-AI 6025.08, Pain Management and Opioid Safety in Military Medical Treatment Facilities, dated 8 Feb 2023 and credentialing requirements. For questions or concerns, please email the Pain Management org box: dha.ncr.j-3.mbx.mhs-pain-management@health.mil.
Update:
Please review the 2022 CDC Opiate Prescribing Guidelines: https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm
Instructions
- Before beginning this course, you must complete the "Department of Defense Opioid Prescriber Safety Training Program (OPST)” in the JKO system. Visit JKO at https://jkodirect.jten.mil/Atlas2/page/login/Login.jsf, and search for the course by name or ID number (1176).
- At the completion/end of the OPST course in JKO, you will receive “How to Obtain CE” information including an access code.
- Return to this DHA J-7 CEPO page (which you're viewing now). (Bookmark it in your browser now, or use the keyword "opioid" to search for this page later.) Click the "Register" tab, and enter the access code that you received from JKO upon completing the course in the JKO system. Then click the "Take Course" tab and the "Take Course" button to begin the course. Note: you will NOT be required to complete all the course requirements (e.g. video and posttest) again. Instead, you will complete a course evaluation survey and then claim your CE/CME credits.
- For CE/CME related questions, support, or accommodations please feel free to contact us at: dha.ncr.j7.mbx.cepo-cms-support@health.mil
Program Description
The Department of Defense (DoD) Opioid Prescriber Safety Training Program stems from the presidential memo, "Addressing Prescription Drug Abuse and Heroin Use," from October 2015 that mandated training for all providers, residents, and clinical trainees in federal health care facilities who prescribe controlled substances. The memo is accessible at http://go.wh.gov/QyMgQT. It was created by tri-service experts and equips providers to improve patient outcomes for substance use disorders and pain management.
This program was developed in 2020 as an update to the previous 2016 DoD Opioid Prescriber Safety Training Program.
Target Audience
This activity provides continuing education for physicians, nurses, physician assistants, pharmacists, pharmacy technicians, and dentists. A certificate of attendance is available for other attendees.
Learning Objectives
- Explain the historical background that influenced the development of Opioid Prescriber Safety Training (OPST).
- Comprehend the importance of the OPST by reviewing outcome data.
- Analyze the Military Health System (MHS) Opioid Prescribing Trends.
- Summarize ways to collaborate with patients to create pain treatment goals that are achievable and relevant to the patient.
- Analyze how to refer and connect appropriate patients with chronic and acute pain for cognitive behavioral therapy for pain.
- Recognize indications for prescribing naloxone to patients.
- Comprehend the substance use disorders (SUDs) and other Behavioral Health (BH) comorbidities that occur when managing pain, the available psychotherapies, and Medication Assisted Treatments (MATs) available within DoD upon referral.
- Recognize the misuse potential and BH related problems that may occur when prescribing controlled substances including overdose, accidental death, and suicide.
- Identify potential Substance Use and Opioid Use Disorders (OUDs).
- List opioid risk mitigation recommendations and increase use of risk mitigation tools and resources.
- Explain key components of the Opioid Overdose Education and Naloxone Distribution (OEND) efforts to increase availability to naloxone to patients at risk.
- Comprehend when an active duty beneficiary’s controlled substance prescription will expire according to the new DoDI 1010.16.
- Compare opioid safety and naloxone prescribing tools in CarePoint.
OPST Resource Document
Below is a link to view and download the OPST Resource Document, which contains links to emails, websites, documents, and articles referenced in the training.
Additional Information
Attachment | Size |
---|---|
2022 CDC Opiate Prescribing Guidelines | 861.82 KB |
Available Credit
- 2.00 AAPADHA J-7 CEPO has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.00 hours of AAPA Category 1 CME credits. Physician assistants should only claim credit commensurate with the extent of their participation.
- 2.00 ACCME Non-Physician CME CreditDHA J-7 CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education. ACCME Non-Physician CME Credit providers will be provided a certificate of participation for educational activities certified for AMA PRA Category 1 Credit™. ACCME Non-Physician CME Credit providers may receive a maximum of 2.00 hours for completing this Internet Activity Enduring Material activity.
- 2.00 ACPE PharmacistUAN JA4008136-0000-21-299-H04-P
No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacists. This knowledge based activity will provide a maximum of 2.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity. - 2.00 ACPE Pharmacy technicianUAN JA4008136-0000-21-299-H04-T
No valid paper/electronic statement of credit will be offered. DHA J-7 CEPO is accredited by the American Council for Pharmacy Education (ACPE) to provide continuing education for Pharmacy Technicians. This knowledge based activity will provide a maximum of 2.00 contact hours of pharmacy continuing education credit. Participant CE records will be electronically communicated to CPE Monitor. There is no cost to participate in this activity. - 2.00 Dentists and Allied Dental Staff (ADA CERP)
DHA, J-7, CEPO is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education (CDE). ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
DHA, J-7, CEPO designates this activity for continuing education credits.
- 2.00 Physicians (ACCME)
DHA, J-7, CEPO is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DHA, J-7, CEPO designated this Internet Activity Enduring Material for a maximum of 2.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 2.00 ANCCThe DHA, J-7, CEPO is accredited by the Joint Accreditation/ Interprofessional Continuing Education (IPCE) to provide this Continuing Nursing Education Internet Activity Enduring Material for a maximum of 2.00 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
- 2.00 Certificate of Attendance
- 2.00 Interprofessional Continuing Education (IPCE)
In support of improving patient care, the DHA, J-7, CEPO is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity was planned by and for the health care team, and learners will receive 2.00 Interprofessional Continuing Education (IPCE) credit for learning and change.